CORTISONE which counteracted local growth of a transplanted non-metastasizing adenocarcinoma in mice stimulated production of metastases of the same tumour (Agosin et al., 1952) . The finding of the Chilean group has been corroborated in work with other transplantable adenocarcinomata (Baserga and Shubik, 1954; Molamut, Spain, Gault and Kreisler, 1952). In the work with the transplantable Krebs-II adenocarcinoma cortisone produced widespread metastases beyond the lung filter, but no such result was obtained with Sarcoma 37 (Pomeroy, 1954) . Likewise, cortisone did not affect the incidence, time of appearance or dclistribution of the anatomic sites of metastases of other transplantable tumours (Kaliss, Borges and Day, 1954; Martinez and Bittner, 1955) .
pieces, was grafted into the spleen. The second ovary was grafted into the spleen of castrated males of the same litter or the same strain. About six months after grafting 2 or 4 pellets containing 40 per cent of cortisone acetate mixed with 60 per cent of cholesterol were implanted beneath the skin. The animals were necropsied 9 to 12 months after grafting the ovary and 3 to 6 months after the action of cortisone had begun. At necropsy three dimensions of the graft were measured with callipers; the product is given as the "size " of the growth. These figures are quoted only to indicate the differences obtained in the various comparative groups of animals; they are stultified by the fact that at necropsy cysts, large and small, mostly haemorrhagic, are unavoidably measured as part of the growth. A more exact comparison of size attained has been reached in another way which will be mentioned later. At necropsy a careful search was made for metastases, especially in the liver and lungs.
RESULTS

Metastases
We had at our disposal 55 animals not receiving cortisone in which ovarian tumours were produced, and 37 animals receiving cortisone in which ovarian tumours though of lesser size were found (Table II) . In none of these 92 animals with ovarian tumours were hepatic metastases present at necropsy performed 302 to 407 days after grafting the ovary into the spleen.
Tiny nodules were found in the lung, especially at or near the pleura, in some ofthese animals, with greater incidence in Balb A. The nodules were as frequent in animals without as with cortisone. At microscopical examination the nodules appeared in some cases very suspect of being metastases of granulosa-cell tumours. But similar nodules are known to appear in the lung of mice spontaneously (Shimkin, 1955) .
Absorption of cortisone was of 30 to 90 /ug./day, during 4 to 6 months ( Table   I) . Production of metastases, as evident from the present work, was not stimulated by the continuous absorption of these quantities of cortisone acetate. Absorption of the corticoid was calculated on the assumption of non-selective absorption (Fuenzalida, 1950; Fuenzalida and Lipschutz, 1953) ; should this assumption be wrong, the quantities ofcortisone absorbed per day would be two and a half times those given above.
Metastases were found in the liver in 4 animals of strain Balb A not belonging to the groups classified in Tables I and II . Two of these animals were females which died at 404 and 431 days after grafting the ovary into the spleen; 2 were males which died at 540 and 570 days. In all the 4 cases the ovarian growths were granulosa-cell tumours. None of these animals had received cortisone.
No metastases were found so far in any animal of the C57bl strain dying at 309 to 644 days. Growth of the intrasplenic ovarian tumour Full evidence was produced in our work that cortisone deeply interferes in the growth of the intrasplenic ovarian tumour. Results obtained are classified in Tables I and II. There was a total of 66 animals not receiving cortisone. The ovary took in 57 animals (Table II) (Klein, 1953) . 
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(1) There was another striking difference between the cortisone and non-cortisone groups: notwithstanding the bewildering variation in the size of the growth, maximal size was invariably smaller in the cortisone group than in the noncortisone groups (Table I , Column 8: Fig. 4 and 5).
Of fundamental importance is also the fact already mentioned above, and to be discussed more fully in the next section, that several tiny grafts in the cortisone groups, especially in the Balb A strain, scarcely deserved to be classed .as tumoural.
To avoid the error in the evaluation of the comparative size of the growths due to cysts the following procedure was adopted. The preparations of the 40 animals of Groups I and II (Table II) were photographed at x 3. The surface occupied by tumourous tissue (granulosa-cell and luteomatous) was then delineated with the control of the microscope (Fig. 6 and 7) . The relation of the total surface of the tumourous tissue in the non-cortisone and cortisone Groups I and II was of 100: 16.
Before proceeding to comparative microscopical observations in the cortisone and non-cortisone groups two interesting facts may be mentioned: the evolution of the ovarian tumour differed, apparently, according to the sex of the host and, certainly, according to the strain.
As seen from Column 6 of Table I the average size of the growths in the noncortisone groups was greater in females than in males (compare I/III and V/VII). Also the maximal size attained in the females of the non-cortisone groups was larger than in males; this rule does not apply to those groups in which the evolution of the tumour was interfered with by cortisone (II/IV and VI/VIII). However, when discussing the comparative growth of the ovarian tumour in both sexes one -must not overlook the fact that we are dealing with ovarian autografts in females and with homografts in males. There is also the conflicting fact that in the work of Klein (1953)the incidence of intrasplenic ovarian tumours was even higher in males than in females! Quite different is the situation when dealing with strain differences. The strain differences between C57bl and Balb A become fully evident when comparing averages in I/V and III/VII. Indeed, as already insisted upon, the notion of the average "size" of these experimental tumours is a very inexact one on account of the heterogeneous structure of the tumours and on account of the bewildering individual variations. But the existence of strain differences in the growth of the tumour becomes more evident when considering the microscopical structure of the tumours.
M1icroscopical observations
As known from former work of the authorities the intrasplenic ovarian growth in mice is predominantly a granulosa-cell tumour (Fig. 8, 9, 10, 12 ). But the growth may contain also luteinized tissue (Fig. 11, 13 ) or may be a pure luteoma (Fig. 14) .
We have classified the microscopical results in Table II according to the following rules: pure granulosa-cell tumours were pooled together with mixed tumours in which granulosa-cell nodules predominated; pure luteomata which were rare, were pooled with mixed tumours in which nodules of luteinized cells predominated. In Groups I and III of Table II In 11 out of 32 cortisone animals of the C57bl strain (II and IV) a pronounced degeneration and hyalinization of the tumoural tissue took place (Fig. 17 ; see also Fig. 13 and 16 ). In most of these animals the hyalinized cells appeared to have been originally luteinized. There were necrotic masses, sometimes with leucocytic infiltration (Fig. 17) : or the greater part of the growth was replaced by loose and oedematous connective tissue. Only one similar case occurred in the Balb A strain (VIII).
As already insisted upon Table II gives also good evidence of strain differences between C57bl and Balb A; no less than 16 out of 25 non-cortisone animals of Balb A with tumours (64 per cent; V and VII) had luteomata whereas luteomata occurred in only 7 out of 30 non-cortisone animals of C57bl with tumours (23 per cent; I and III). This statement is of great interest as there is seemingly not much difference between various strains as to incidence of tumours in the intrasplenic ovarian graft as shown also by the work ofKlein (1952, 1953) with various strains (see also Gardner, 1955) . Indeed, one must not overlook that figures referring to incidence of tumours depend on the arbitrary criterion in classifying the disorderly grown ovarian tissues as tumourous or non-tumourous.
DISCUSSION
Full evidence is offered that metastatic spread of intrasplenic ovarian granulosacell tumours or luteomata was not stimulated by the quantitites of cortisone acetate we have administered. Indeed, one may insist that the quantities absorbed from cortisone pellets were smaller than those given in daily injections by the authorities who have worked with transplanted tumours. However, on the other hand, one may argue that in our work absorption was a continuous one which greatly enhances the activity of steriods. This was evidenced also in preliminary experiments in which pellets of pure cortisone acetate were implanted subcutaneously, with an absorption of about 400 ,g. per day. The animals died, without exception, at about 30 days of cortisone treatment.
In our experiments the action of cortisone acetate was prolonged for 4 to 6 months, without metastases being produced, or better without metastatic spread being enhanced, since in experiments of longer duration metastases occurred in non-cortisone animals of one of the strains used.
On the other hand, the quantities of cortisone acetate given in our experiments which failed to enhance metastatic spread, were sufficient to interfere in a deepgoing manner in the evolution of the ovarian tumour. This makes it all the less probable that the failure as to metastatic spread was due to insufficient quantities of cortisone having been administered.
We must now ask in which way cortisone produced inhibition of growth of the intrasplenic ovarian tumour. At the actual moment no definite statements can be made as to this. Retardation of growth of transplantable tumours has been supposed to be due to a change in the environment of the tumour and more specifically to the delay in new blood vessel formation (Antopol, Glaubach and Graff, 1954) . In our work the action of cortisone was made to begin only about 4 to 6 months after grafting. There were signs of degeneration in 12 out of 50 animals with cortisone (Table II) . This condition can be brought in harmony with the concept of the inhibitory action of cortisone being localized in the immediate environment of the tumour. But certain observations would allow for another explanation which we must discuss here.
One of the outstanding differences between the cortisone and non-cortisone groups was the considerable diminution of the incidence of granulosa-cell tumours which took place in all groups, with the exception of the Balb A males in which the incidence of granulosa-cell tumours was already small in the non-cortisone group. The diminution of incidence of granulosa-cell tumours in C57bl females under the influence of cortisone was paralleled by an increased incidence of animals with luteomata plus animals with luteomatous nodules not yet deserving to be classed as tumourous. Most cases with degeneration also belonged to the luteomatous pattern. The same seems to be true for males C57bl where there was only one animal with luteoma but a large number of animals with degenerated luteomatous tissue or animals with small luteomatous nodules not classed as tumours. Since the evolution of the intrasplenic ovarian growth-granulosa-cell tumours or alternatively luteomata-depends undoubtedly on a specific pattern of the uncontrolled delivery of hypophysial gonadotrophic hormones one may tentatively suggest that the antitumourigenic action of cortisone was due to an interference with the production or delivery of these hormones. The ovarian tumoural constellation in C57bl in which granulosa-cell tumours predominate approaches, under the influence of cortisone, that of the guinea-pig in which luteomata or small luteomatous nodules predominate in the first two years aftet grafting. Column 8 of Table II summarizes the displacement from predominance of the granulosa-cell tumnour to predominance of the luteomatous reaction. It may be mentioned here that in our work with the antiluteinizing action of different steroids (Mardones, Iglesias and Lipschutz, 1956) The quantities of cortisone acetate administered greatly slowed down the growth of the intrasplenic ovarian tumours in both strains used.
The microscopical structure of the tumours also was fundamentally influenced by cortisone: the incidence of granulosa-cell tumours greatly diminished and the incidence of luteomata plus luteomatous nodules increased.
The small luteomatous ovarian growths, tumoural or non-tumoural, in the two strains of mice treated with cortisone were similar to the slowly growing intrasplenic ovarian growtihs in the guinea-pig in the first two years after grafting.
The tentative suggestion is made that the antitumourigenic action of cortisone was by interference with the production or delivery of gonadotrophic hypophysial hormones on which ovarian tumourigenesis in intrasplenic grafts depends.
If this interpretation were true the results obtained would suggest that differences as to the evolution of intrasplenic ovarian tumours between guinea-pigs and mice, or between different strains of mice, should be explained by a genetically determined difference in the pattern of the steroid homeostasis. The results obtained would likewise offer a new example of how a tumourigenic deviation of the gonadotrophic function of the hypophysis can be influenced by a corticoid whose production in the body is dependent on the corticotrophic function of the hypophysis.
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